NCT03830528View on ClinicalTrials.gov

A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Parkinson's Disease
Interventions
DRUG

KW-6356 Low Dose

KW-6356 will be administered as single doses.

DRUG

KW-6356 Middle Dose

KW-6356 will be administered as single doses.

DRUG

KW-6356 High Dose

KW-6356 will be administered as single doses.

DRUG

KW-6356 X Dose

KW-6356 will be administered as multiple doses.

DRUG

KW-6356 Y Dose

KW-6356 will be administered for Japanese healthy men as multiple doses.

DRUG

Placebo

All study cohorts (except Part C) are placebo controlled.

Trial Locations (1)

Unknown

Medical Co. LTA Sumida Hospital, Tokyo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03830528 - A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects | Biotech Hunter | Biotech Hunter